Jazz Pharmaceuticals plc (JAZZ)

SEC filing

Jazz Pharmaceuticals plc

JAZZ · CIK 1232524

4 · Aug 31, 2026 · EVP, Global Head of R&D & CMO Iannone Robert sold 76.92K shares at $249.70/share ($19.2M); exercised options for 115K shares

EVP, Global Head of R&D & CMO Iannone Robert sold 76.92K shares at $249.70/share ($19.2M); exercised options for 115K shares

PRIMARY DOCUMENT

xslF345X06/edgardoc.xmlSEC.gov

Graphics and non-inline formats (not embedded below).